Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Prepaid Assets: 2019-2025

Historic Prepaid Assets for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $4.9 million.

  • Eton Pharmaceuticals' Prepaid Assets rose 152.27% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 152.27%. This contributed to the annual value of $5.5 million for FY2024, which is 386.45% up from last year.
  • Eton Pharmaceuticals' Prepaid Assets amounted to $4.9 million in Q3 2025, which was up 2.53% from $4.8 million recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Prepaid Assets high stood at $5.5 million for Q4 2024, and its period low was $541,000 during Q3 2023.
  • In the last 3 years, Eton Pharmaceuticals' Prepaid Assets had a median value of $1.1 million in 2023 and averaged $2.3 million.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Prepaid Assets crashed by 59.40% in 2022, and later skyrocketed by 503.25% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Prepaid Assets (MRQ) stood at $3.2 million in 2021, then tumbled by 59.40% to $1.3 million in 2022, then decreased by 12.48% to $1.1 million in 2023, then skyrocketed by 386.45% to $5.5 million in 2024, then dropped by 10.01% to $4.9 million in 2025.
  • Its Prepaid Assets stands at $4.9 million for Q3 2025, versus $4.8 million for Q2 2025 and $2.5 million for Q1 2025.